发明公开
- 专利标题: SOLUBLE RECEPTOR BR43X2 AND METHODS OF USING THEM FOR THERAPY
- 专利标题(中): 可溶性受体BR43x2和方法用于治疗用途
-
申请号: EP00902354.0申请日: 2000-01-07
-
公开(公告)号: EP1141274A2公开(公告)日: 2001-10-10
- 发明人: GROSS, Jane, A. , XU, Wenfeng , MADDEN, Karen , YEE, David, P.
- 申请人: ZymoGenetics, Inc.
- 申请人地址: 1201 Eastlake Avenue East Seattle, WA 98102 US
- 专利权人: ZymoGenetics, Inc.
- 当前专利权人: ZymoGenetics, Inc.
- 当前专利权人地址: 1201 Eastlake Avenue East Seattle, WA 98102 US
- 代理机构: Schlich, George William
- 优先权: US226533 19990107
- 国际公布: WO0040716 20000713
- 主分类号: C12N15/11
- IPC分类号: C12N15/11 ; C07K14/705 ; A61K38/17 ; A61K39/395
摘要:
Soluble, secreted tumor necrosis factor receptor polypeptides, polynucleotides encoding the polypeptides, and related compositions and methods are disclosed. The polypeptides comprise one cysteine-rich repeat that is homologous to other tumor necrosis factor receptors, such as transmembrane activator and CAML-interactor (TACI). The polypeptides may be used for detecting ligands, agonists and antagonists. The polypeptides may also be used in methods that modulate B cell activation.
公开/授权文献
信息查询
IPC分类: